LIONVILLE, Pa., Oct. 21 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. , today announced that it has elected Paula A. Johnson, M.D., MPH, to its Board of Directors.
Dr. Johnson is a cardiologist and is the Executive Director of the Connors Center for Women’s Health and Gender Biology, Chief of the Division of Women’s Health and founder of the Center for Cardiovascular Disease in Women, at Brigham and Women’s Hospital in Boston. She is also an Associate Professor at Harvard Medical School.
“We are fortunate to have Dr. Johnson join our Board of Directors. Her background as a practicing physician and experience in health care systems operations strongly relates to our business,” said Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer. “As our business continues to grow, we believe she will prove to be a valuable asset to our Board.”
Dr. Johnson is a graduate of Harvard and Radcliffe Colleges and currently serves on several not-for-profit boards, including Planned Parenthood League of Massachusetts and the Greater Boston Division of the American Heart Association.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. is the world’s premier manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. West’s customers include the world’s leading pharmaceutical, biotechnology, generic drug and medical device producers. Headquartered in Lionville, Pennsylvania, West Pharmaceutical Services supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at http://www.westpharma.com
West Pharmaceutical Services, Inc.
CONTACT: Michael A. Anderson, Vice President and Treasurer of WestPharmaceutical Services, Inc., +1-610-594-3345,mike_anderson@westpharma.com; or Investors and Financial Media - JulieHuang, or Theresa Kelleher both of Financial Dynamics, +1-212-850-5600,wst@fd-us.com; or Media - Stacey Holifield of Schwartz Communication,+1-781-684-0770, westpharma@schwartz-pr.com
Web site: http://www.westpharma.com/
